4.4 Article

The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts

期刊

BIOCHEMICAL SOCIETY TRANSACTIONS
卷 41, 期 -, 页码 741-749

出版社

PORTLAND PRESS LTD
DOI: 10.1042/BST20130010

关键词

deacetylase; gene expression; histone deacetylase 1 (HDAC1); histone deacetylase 2 (HDAC2)

资金

  1. Biotechnology and Biological Sciences Research Council [BB/J009598/1]
  2. Medical Research Council [MR/J009202/1]
  3. BBSRC [BB/J009598/1] Funding Source: UKRI
  4. MRC [G0600135, MR/J009202/1] Funding Source: UKRI
  5. Biotechnology and Biological Sciences Research Council [BB/J009598/1] Funding Source: researchfish
  6. Medical Research Council [MR/J009202/1, G0600135] Funding Source: researchfish

向作者/读者索取更多资源

HDACs (histone deacetylases) 1 and 2 are ubiquitous long-lived proteins, which are often found together in three major multiprotein co-repressor complexes: Sin3, NuRD (nucleosome remodelling and deacetylation) and CoREST (co-repressor for element-1-silencing transcription factor). Although there is a burgeoning number of non-histone proteins within the acetylome, these complexes contain multiple DNA/chromatin-recognition motifs, which, in combination with transcription factors, target HDAC1/2 to chromatin. Their physiological roles should therefore be viewed within the framework of chromatin manipulation. Classically, HDACs were thought to be recruited predominantly by transcriptional repressors to facilitate local histone deacetylation and transcriptional repression. More recently, genome-wide assays have mapped HDAC1/2 and their associated proteins to transcriptionally active loci and have provided alternative context-specific functions, whereby their repressive functions are subtly exerted to balance transcriptional activation and repression. With a few significant exceptions (early embryogenesis, brain development), HDAC1 and HDAC2 are functionally redundant. In most mouse knockout studies, deletion of both enzymes is required in order to produce a substantial phenotype. HDAC1/2 activity has been implicated in the development of numerous tissue and cell types, including heart, skin, brain, B-cells and T-cells. A common feature in all HDAC1/2-knockout, -knockdown and small-molecule inhibitor studies is a reduction in cell proliferation. A generic role in cell cycle progression could be exploited in cancer cells, by blocking HDAC1/2 activity with small-molecule inhibitors, making them potentially useful drug targets.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据